Ikarian Capital »

Celcuity shares owned by Ikarian Capital

Quarter-by-quarter ownership of Celcuity (CELC) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 106k 99.74
2025-03-31 $554k 55k 10.11

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Celcuity

Baker Bros. Advisors
NEA Management Company
venBio Select Advisor
Perceptive Advisors
BlackRock
Vanguard Group
Soleus Capital Management
Deerfield Management Company
State Street Corporation
Tang Capital Management
Geode Capital Management
Sio Capital Management
Holocene Advisors
BVF
Goldman Sachs Group

View all funds holding Celcuity